KAS
KIDS icon

Kemnay Advisory Services’s OrthoPediatrics KIDS Stock Holding History

Kemnay Advisory Services’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,859
Closed -$45.4K – 1273
2026
Q1 		$45.4K Buy
+2,859
New +$50K 0.01% 294

Other funds holding KIDS

Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Kemnay Advisory Services's KIDS Position: Q2 2026 in Review

Kemnay Advisory Services sold out of OrthoPediatrics (KIDS) in Q2 2026, closing a stake of 2,859 shares — an estimated $45.4K sold.

Kemnay Advisory Services first reported a position in KIDS in Q1 2026 and held it in 1 quarter. The position peaked at $45.4K in Q1 2026. 119 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.

  • Kemnay Advisory Services reported no remaining OrthoPediatrics position as of Q2 2026 after selling out during the quarter.
  • Kemnay Advisory Services sold 2,859 OrthoPediatrics shares in Q2 2026, an estimated $45.4K.
  • Kemnay Advisory Services first reported a position in OrthoPediatrics in Q1 2026 and held it in 1 quarter.
  • Kemnay Advisory Services's OrthoPediatrics position peaked at $45.4K in Q1 2026.
  • 119 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.